4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agari, T; Borlongan, CV; Date, I; Kondo, A; Kuramoto, S; Matsui, T; Miyoshi, Y; Shingo, T; Yasuhara, T | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |